DEFINITIVE NOTICE AND PROXY

Company

TENAX THERAPEUTICS, INC.

Filed

August 27, 2010

Period of Report

September 24, 2010

Accession Number

0001193125-10-199321

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →